Literature DB >> 24978596

Serum adiposity-induced biomarkers in obese and lean children with recently diagnosed autoimmune type 1 diabetes.

M J Redondo1, L M Rodriguez, M W Haymond, C S Hampe, E O Smith, A Balasubramanyam, S Devaraj.   

Abstract

BACKGROUND/
OBJECTIVE: Obesity increases the risk of cardiovascular disease and diabetic complications in type 1 diabetes. Adipokines, which regulate obesity-induced inflammation, may contribute to this association. We compared serum adipokines and inflammatory cytokines in obese and lean children with new-onset autoimmune type 1 diabetes. SUBJECTS AND METHODS: We prospectively studied 32 lean and 18 obese children (age range: 2-18 yr) with new-onset autoimmune type 1 diabetes and followed them for up to 2 yr. Serum adipokines [leptin, total and high molecular weight (HMW) adiponectin, omentin, resistin, chemerin, visfatin], cytokines [interferon (IFN)-gamma, interleukin (IL)-10, IL-12, IL-6, IL-8, and tumor necrosis factor (TNF)-alpha] and C-reactive protein (CRP) were measured at a median of 7 wk after diagnosis (range: 3-16 wk).
RESULTS: Lean children were 71.9% non-Hispanic White, 21.9% Hispanic, and 6.3% African-American, compared with 27.8, 55.6, and 16.7%, respectively, for obese children (p = 0.01). Compared with lean children, obese children had significantly higher serum leptin, visfatin, chemerin, TNF-alpha and CRP, and lower total adiponectin and omentin after adjustment for race/ethnicity and Tanner stage. African-American race was independently associated with higher leptin among youth ≥10 yr (p = 0.007). Leptin levels at onset positively correlated with hemoglobin A1c after 1-2 yr (p = 0.0001) independently of body mass index, race/ethnicity, and diabetes duration. Higher TNF-alpha was associated with obesity and female gender, after adjustment for race/ethnicity (p = 0.0003).
CONCLUSION: Obese children with new-onset autoimmune type 1 diabetes have a proinflammatory profile of circulating adipokines and cytokines that may contribute to the development of cardiovascular disease and diabetic complications.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  IFN-gamma; IL-10; IL-12; IL-6; IL-8; TNF-alpha; adipokine; adiponectin; chemerin; children; cytokines; leptin; obesity; omentin; resistin; type 1 diabetes; visfatin

Mesh:

Substances:

Year:  2014        PMID: 24978596      PMCID: PMC4423898          DOI: 10.1111/pedi.12159

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  39 in total

Review 1.  Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation.

Authors:  Paresh Dandona; Ahmad Aljada; Ajay Chaudhuri; Priya Mohanty; Rajesh Garg
Journal:  Circulation       Date:  2005-03-22       Impact factor: 29.690

Review 2.  Inflammation and metabolic disorders.

Authors:  Gökhan S Hotamisligil
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

3.  Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study.

Authors:  Christopher C Patterson; Gisela G Dahlquist; Eva Gyürüs; Anders Green; Gyula Soltész
Journal:  Lancet       Date:  2009-05-27       Impact factor: 79.321

4.  Decreased plasma omentin-1 levels in Type 1 diabetes mellitus.

Authors:  B K Tan; S Pua; F Syed; K C Lewandowski; J P O'Hare; H S Randeva
Journal:  Diabet Med       Date:  2008-10       Impact factor: 4.359

Review 5.  Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism.

Authors:  Arya M Sharma; Bart Staels
Journal:  J Clin Endocrinol Metab       Date:  2006-12-05       Impact factor: 5.958

6.  Role of leptin in the neuroendocrine response to fasting.

Authors:  R S Ahima; D Prabakaran; C Mantzoros; D Qu; B Lowell; E Maratos-Flier; J S Flier
Journal:  Nature       Date:  1996-07-18       Impact factor: 49.962

7.  Leptin before and after insulin therapy in children with new-onset type 1 diabetes.

Authors:  K Hanaki; D J Becker; S A Arslanian
Journal:  J Clin Endocrinol Metab       Date:  1999-05       Impact factor: 5.958

8.  The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes.

Authors:  Shilpa Oak; Lisa K Gilliam; Mona Landin-Olsson; Carina Törn; Ingrid Kockum; Christina R Pennington; Merrill J Rowley; Michael R Christie; J Paul Banga; Christiane S Hampe
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-26       Impact factor: 11.205

9.  Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose.

Authors:  Bee K Tan; Raghu Adya; S Farhatullah; Kris C Lewandowski; Paul O'Hare; Hendrik Lehnert; Harpal S Randeva
Journal:  Diabetes       Date:  2008-01-03       Impact factor: 9.461

10.  Chemerin is a novel adipokine associated with obesity and metabolic syndrome.

Authors:  Kiymet Bozaoglu; Kristy Bolton; Janine McMillan; Paul Zimmet; Jeremy Jowett; Greg Collier; Ken Walder; David Segal
Journal:  Endocrinology       Date:  2007-07-19       Impact factor: 4.736

View more
  16 in total

1.  Body mass index and adiposity indicators associated with cardiovascular biomarkers in youth with type 1 diabetes followed prospectively.

Authors:  L M Lipsky; B Gee; A Liu; T R Nansel
Journal:  Pediatr Obes       Date:  2016-07-15       Impact factor: 4.000

2.  Relationship of adiponectin and leptin with autoimmunity in children with new-onset type 1 diabetes: a pilot study.

Authors:  Natalie Hecht Baldauff; Hala Tfayli; Wenxiu Dong; Vincent C Arena; Nursen Gurtunca; Massimo Pietropaolo; Dorothy J Becker; Ingrid M Libman
Journal:  Pediatr Diabetes       Date:  2015-03-05       Impact factor: 4.866

3.  Study of Visfatin Level in Type 1 Diabetic Children and Adolescents.

Authors:  Mona H El Samahi; Nagwa Abdallah Ismail; Randa M Matter; Abeer Selim; Alshaymaa Ahmed Ibrahim; Walaa Nabih
Journal:  Open Access Maced J Med Sci       Date:  2017-06-11

4.  Greater inflammation and adiposity are associated with lower bone mineral density in youth with type 1 diabetes.

Authors:  Namrata Sanjeevi; Leah M Lipsky; Tonja R Nansel
Journal:  Diabetes Res Clin Pract       Date:  2018-08-13       Impact factor: 5.602

5.  Pigment Epithelium-Derived Factor Declines in Response to an Oral Glucose Load and Is Correlated with Vitamin D and BMI but Not Diabetes Status in Children and Young Adults.

Authors:  Allison C Sylvetsky; Najy T Issa; Avinash Chandran; Rebecca J Brown; Hussam J Alamri; Gabriella Aitcheson; Mary Walter; Kristina I Rother
Journal:  Horm Res Paediatr       Date:  2017-04-11       Impact factor: 2.852

6.  Serum adipokine levels in patients with type 1 diabetes are associated with degree of obesity but only resistin is independently associated with atherosclerosis markers.

Authors:  Erieta Kollari; Ioanna Zografou; Christos Sampanis; Vasilios G Athyros; Triantafyllos Didangelos; Christos S Mantzoros; Asterios Karagiannis
Journal:  Hormones (Athens)       Date:  2021-10-30       Impact factor: 2.885

Review 7.  Inflammation Markers in Type 2 Diabetes and the Metabolic Syndrome in the Pediatric Population.

Authors:  Thomas Reinehr; Christian Ludwig Roth
Journal:  Curr Diab Rep       Date:  2018-10-18       Impact factor: 4.810

Review 8.  Psychosocial aspects of type 1 diabetes in Latino- and Asian-American youth.

Authors:  Kajal K Gandhi; Tom Baranowski; Barbara J Anderson; Nidhi Bansal; Maria J Redondo
Journal:  Pediatr Res       Date:  2016-04-13       Impact factor: 3.756

9.  CHEMERIN AND FACTORS RELATED TO CARDIOVASCULAR RISK IN CHILDREN AND ADOLESCENTS: A SYSTEMATIC REVIEW.

Authors:  Vanessa Sequeira Fontes; Felipe Silva Neves; Ana Paula Carlos Cândido
Journal:  Rev Paul Pediatr       Date:  2018-01-15

10.  Anthropometry Versus Imaging for Prediction of Inflammation Among Hispanic Girls.

Authors:  Jennifer W Bea; Janet Funk; Megan Hetherington-Rauth; Betsy C Wertheim; Lucia Mosquiera; Ravina Thuraisingam; Vinson Lee; Robert Blew; Timothy Lohman; Denise J Roe; Scott Going
Journal:  Obesity (Silver Spring)       Date:  2018-10       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.